In Depression Rimarex 150mg Capsule helps in maintaining the balance of certain chemicals in the brain that affect mood and behavior. It helps you sleep better and increases your energy levels. This improves your mood, relieves anxiety, tension, prevents extreme mood changes, and helps you feel less agitated. You may experience fewer episodes of depression and low mood. It can take several weeks for this medicine to work and you may still feel low during this time. It is likely that you will take this medicine for at least six months but possibly much longer. It needs to be taken regularly to work effectively. Do not stop taking it unless your doctor tells you to.
Caution is advised when consuming alcohol with Rimarex 150mg Capsule. Please consult your doctor.
Rimarex 150mg Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Rimarex 150mg Capsule is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Rimarex 150mg Capsule does not usually affect your ability to drive.
Rimarex 150mg Capsule is safe to use in patients with kidney disease. No dose adjustment of Rimarex 150mg Capsule is recommended.
Rimarex 150mg Capsule should be used with caution in patients with severe liver disease. Dose adjustment of Rimarex 150mg Capsule may be needed. Please consult your doctor.
If you miss a dose of Rimarex 150mg Capsule, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Micro Labs Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Intas Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)